001     270813
005     20240808164535.0
024 7 _ |a pmc:PMC11262230
|2 pmc
024 7 _ |a 10.1080/15548627.2024.2334111
|2 doi
024 7 _ |a pmid:38522425
|2 pmid
024 7 _ |a 1554-8627
|2 ISSN
024 7 _ |a 1538-4101
|2 ISSN
024 7 _ |a 1551-4005
|2 ISSN
024 7 _ |a 1554-8635
|2 ISSN
037 _ _ |a DZNE-2024-00903
041 _ _ |a English
082 _ _ |a 570
100 1 _ |a Brunialti, Electra
|0 0000-0002-0247-3819
|b 0
245 _ _ |a Design and validation of a reporter mouse to study the dynamic regulation of TFEB and TFE3 activity through in vivo imaging techniques.
260 _ _ |a Abingdon, Oxon
|c 2024
|b Taylor & Francis
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1722842960_8792
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a ISSN 1554-8635 not unique: **2 hits**.
520 _ _ |a TFEB and TFE3 belong to the MiT/TFE family of transcription factors that bind identical DNA responsive elements in the regulatory regions of target genes. They are involved in regulating lysosomal biogenesis, function, exocytosis, autophagy, and lipid catabolism. Precise control of TFEB and TFE3 activity is crucial for processes such as senescence, stress response, energy metabolism, and cellular catabolism. Dysregulation of these factors is implicated in various diseases, thus researchers have explored pharmacological approaches to modulate MiT/TFE activity, considering these transcription factors as potential therapeutic targets. However, the physiological complexity of their functions and the lack of suitable in vivo tools have limited the development of selective MiT/TFE modulating agents. Here, we have created a reporter-based biosensor, named CLEARoptimized, facilitating the pharmacological profiling of TFEB- and TFE3-mediated transcription. This innovative tool enables the measurement of TFEB and TFE3 activity in living cells and mice through imaging and biochemical techniques. CLEARoptimized consists of a promoter with six coordinated lysosomal expression and regulation motifs identified through an in-depth bioinformatic analysis of the promoters of 128 TFEB-target genes. The biosensor drives the expression of luciferase and tdTomato reporter genes, allowing the quantification of TFEB and TFE3 activity in cells and in animals through optical imaging and biochemical assays. The biosensor's validity was confirmed by modulating MiT/TFE activity in both cell culture and reporter mice using physiological and pharmacological stimuli. Overall, this study introduces an innovative tool for studying autophagy and lysosomal pathway modulation at various biological levels, from individual cells to the entire organism.Abbreviations: CLEAR: coordinated lysosomal expression and regulation; MAR: matrix attachment regions; MiT: microphthalmia-associated transcription factor; ROI: region of interest; TBS: tris-buffered saline; TF: transcription factor; TFE3: transcription factor binding to IGHM enhancer 3; TFEB: transcription factor EB; TH: tyrosine hydroxylase; TK: thymidine kinase; TSS: transcription start site.
536 _ _ |a 352 - Disease Mechanisms (POF4-352)
|0 G:(DE-HGF)POF4-352
|c POF4-352
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Autophagy
|2 Other
650 _ 7 |a drug discovery
|2 Other
650 _ 7 |a luciferase
|2 Other
650 _ 7 |a lysosomal pathway
|2 Other
650 _ 7 |a non-invasive study of TFEB and TFE3
|2 Other
650 _ 7 |a optical imaging
|2 Other
650 _ 7 |a Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
|2 NLM Chemicals
650 _ 7 |a Tcfeb protein, mouse
|2 NLM Chemicals
650 _ 7 |a Tcfe3 protein, mouse
|0 136896-33-8
|2 NLM Chemicals
650 _ 7 |a TFE3 protein, human
|2 NLM Chemicals
650 _ 7 |a TFEB protein, human
|2 NLM Chemicals
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Basic Helix-Loop-Helix Leucine Zipper Transcription Factors: metabolism
|2 MeSH
650 _ 2 |a Mice
|2 MeSH
650 _ 2 |a Lysosomes: metabolism
|2 MeSH
650 _ 2 |a Genes, Reporter
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Promoter Regions, Genetic: genetics
|2 MeSH
650 _ 2 |a Autophagy
|2 MeSH
650 _ 2 |a Biosensing Techniques: methods
|2 MeSH
650 _ 2 |a Gene Expression Regulation: drug effects
|2 MeSH
700 1 _ |a Rizzi, Nicoletta
|0 0000-0001-7075-2759
|b 1
700 1 _ |a Pinto-Costa, Rita
|0 P:(DE-2719)9001609
|b 2
|u dzne
700 1 _ |a Villa, Alessandro
|0 0000-0002-7445-916X
|b 3
700 1 _ |a Panzeri, Alessia
|0 0009-0001-5142-2698
|b 4
700 1 _ |a Meda, Clara
|0 0000-0003-3524-2010
|b 5
700 1 _ |a Rebecchi, Monica
|b 6
700 1 _ |a Di Monte, Donato A
|0 P:(DE-2719)2481741
|b 7
700 1 _ |a Ciana, Paolo
|0 0000-0001-5771-5638
|b 8
773 _ _ |a 10.1080/15548627.2024.2334111
|g Vol. 20, no. 8, p. 1879 - 1894
|0 PERI:(DE-600)2262043-6
|n 8
|p 1879 - 1894
|t Autophagy
|v 20
|y 2024
|x 1554-8627
856 4 _ |u https://pub.dzne.de/record/270813/files/DZNE-2024-00903%20SUP.zip
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/270813/files/DZNE-2024-00903.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/270813/files/DZNE-2024-00903.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:270813
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)9001609
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 7
|6 P:(DE-2719)2481741
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-352
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms
|x 0
914 1 _ |y 2024
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-08-29
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b AUTOPHAGY : 2022
|d 2023-08-29
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-08-29
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b AUTOPHAGY : 2022
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-29
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-29
920 1 _ |0 I:(DE-2719)1013008
|k AG Di Monte
|l Neurodegeneration and Neuroprotection in Parkinson´s Disease
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1013008
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21